{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:47:08Z","timestamp":1793332028870,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.urolonc.2024.01.026","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T03:50:47Z","timestamp":1709351447000},"page":"159.e1-159.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Performance of standard systematic biopsy versus MRI\/TRUS fusion biopsy using the Navigo\u00ae system in contemporary cohort"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9179-7710","authenticated-orcid":false,"given":"Omri","family":"Nativ","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Shefler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Bejar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Peschansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Lavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cohen","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Nativ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2024.01.026_bib0001","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0022-5347(01)61785-3","article-title":"Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng\/ml. or less","volume":"161","author":"Carvalhal","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0002","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa0810084","article-title":"Screening and prostate-cancer mortality in a randomized European study","volume":"360","author":"Schr\u00f6der","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0003","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0022-5347(05)00327-7","article-title":"Pathological characteristics of prostate cancer detected through prostate specific antigen-based screening","volume":"175","author":"Loeb","year":"2006","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.026_bib0004","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.2014.17942","article-title":"Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer","volume":"313","author":"Siddiqui","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.026_bib0005","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.eururo.2019.04.043","article-title":"Magnetic resonance imaging-targeted biopsy versus systematic biopsy in the detection of prostate cancer: a systematic review and meta-analysis","volume":"76","author":"Kasivisvanathan","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0006","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1148\/radiol.2020190646","article-title":"Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the society of abdominal radiology prostate cancer disease-focused panel","volume":"296","author":"Westphalen","year":"2020","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.urolonc.2024.01.026_bib0007","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.euo.2020.02.005","article-title":"Factors influencing variability in the performance of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer: a systematic literature review","volume":"3","author":"Stabilea","year":"2020","journal-title":"Eur Urol Oncl"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS prostate IMAGING: reporting and data system: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0009","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason Grading Prostatic Carcinoma Definition of Grading Patterns and Proposal for a New Grading System","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0010","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","article-title":"Prostate cancer screening with PSA and MRI followed by targeted biopsy only","volume":"387","author":"Hugosson","year":"2022","journal-title":"NEJM"},{"issue":"2","key":"10.1016\/j.urolonc.2024.01.026_bib0011","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.euo.2023.01.003","article-title":"Best current practice and research priorities in active surveillance for prostate cancer: a report of a Movember International Consensus Meeting","volume":"6","author":"Moore","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0012","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.eururo.2021.05.001","article-title":"Reliability of serial prostate magnetic resonance imaging to detect prostate cancer progression during active surveillance: a systematic review and meta-analysis","volume":"80","author":"Rajwa","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0013","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/JU.0000000000002120","article-title":"Systematic versus targeted magnetic resonance imaging\/ultrasound fusion prostate biopsy among men with visible lesions","volume":"207","author":"Patel","year":"2022","journal-title":"J. Urol"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0014","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamaoncol.2020.7589","article-title":"Comparison of multiparametric magnetic resonance imaging targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial","volume":"7","author":"Klotz","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0015","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.026_bib0016","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/bju.15876","article-title":"Incidence of significant prostate cancer after negative MRI and systematic biopsy in the FUTURE trial","volume":"131","author":"Exterkate","year":"2023","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0017","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.eururo.2015.03.041","article-title":"A randomized controlled trial to assess and compare the outcomes of two-core prostate biopsy guided by fused magnetic resonance and transrectal ultrasound images and traditional 12-core systematic biopsy","volume":"69","author":"Baco","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0018","first-page":"1","article-title":"Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: a randomized study","volume":"33","author":"Panebianco","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0019","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.juro.2007.08.124","article-title":"Renal mass biopsy: a renaissance?","volume":"179","author":"Lane","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0021","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.eururo.2018.11.031","article-title":"Detection of individual prostate cancer foci via multiparametric magnetic resonance imaging","volume":"75","author":"Johnson","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0022","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.juro.2016.07.084","article-title":"Magnetic resonance imaging underestimation of prostate cancer geometry: use of patient specific molds to correlate images with whole-mount pathology","volume":"197","author":"Priester","year":"2017","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.01.026_bib0023","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.euo.2023.04.006","article-title":"Head-to-head comparison of 18F-PSMA-1007 positron emission tomography\/computed tomography and multiparametric magnetic resonance imaging with whole-mount histopathology as reference in localization and staging of primary prostate cancer","volume":"6","author":"Exterkate","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0024","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.urology.2023.03.014","article-title":"Use of IsoPSA with prostate MRI PIRADS score may help refine biopsy decision making in patients with elevated PSA","volume":"176","author":"Benidir","year":"2023","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2024.01.026_bib0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11912-023-01371-y","article-title":"The evidence for using artificial intelligence to enhance prostate cancer MR imaging","volume":"25","author":"Canellas","year":"2023","journal-title":"Curr Oncol Rep"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T22:42:54Z","timestamp":1712875374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924000425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1078143924000425"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.026","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of standard systematic biopsy versus MRI\/TRUS fusion biopsy using the Navigo\u00ae system in contemporary cohort","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}